MULTIPARAMETRIC ULTRASOUND IN THE DIAGNOSIS OF LIVER TUMORS
https://doi.org/10.35401/2500-0268-2021-21-1-72-78
Abstract
Liver neoplasms represent a group of tumors of benign and malignant nature, and their differential diagnosis is rather challenging. At present, it becomes necessary to select a non-invasive, highly informative and sufficient research method for solving diagnostic problems, staging and treating focal liver lesions. Ultrasound examination using modern technologies has advantages in the diagnosis of focal liver disease. The review highlights ultrasound differential and diagnostic signs of focal liver tumors when using various methods of ultrasound diagnostics.
About the Authors
A. N. Katrich
Research Institute – Ochapovsky Regional Hospital no.1;
Kuban State Medical Uiversity
Russian Federation
Russian Federation
Cand. of Sci. (Med.), Head of the Ultrasound Diagnostics Department; Associate Professor, Department of Surgery no. 1, Department of Proficiency Enhancement
ul. 1 Maya, 167, Krasnodar, 350086
S. V. Polshikov
Research Institute – Ochapovsky Regional Hospital no. 1
Russian Federation
Russian Federation
Ultrasonic Medical Investigation Specialist, Ultrasound Diagnostics Department
ul. 1 Maya, 167, Krasnodar, 350086
References
1. Claudon M, Dietrich C, Choi B, et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver – update 2012: a WFUMBEFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol. 2013;39(2):187–210. PMID: 23137926. https://doi.org/10.1016/j.ultrasmedbio.2012.09.002
2. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953. PMID: 30350310. https://doi.org/10.1002/ijc.31937
3. Kaprin AD, Starinsky VV, Petrova GV (eds). The State of Cancer Care for the Population of Russia in 2016. P.A. Gertsen Moscow Scientific and Research Oncology Institute, Branch of National Medical Research Center of Radiology; 2017. (In Russ.).
4. Kyzhyrov ZhN, Baimakhanov BB, Sakhipov MM, Chormanov AT, Birzhanbekov NN, Serikuly E. Diagnosis of focal liver disease. Vestnik Kazakhskogo natsionalnogo meditsinskogo universiteta. 2016;1:422–427. (In Russ.).
5. Singal A, Conjeevaram H, Volk M, et al. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev. 2012;21(5):793–799. PMID: 22374994. PMCID: PMC5640437. https://doi.org/10.1158/1055-9965.EPI-11-1005
6. Heimbach J, Kulik L, Finn R. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. PMID: 28130846. https://doi.org/10.1002/hep.29086
7. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–943. PMID: 22424438. https://doi.org/10.1016/j.jhep.2011.12.001
8. Mitkov VV (ed.). A Practical Guide to Ultrasound Diagnostics. General Ultrasound Diagnostics. 3rd ed. Vidar; 2019. (In Russ.).
9. Lencioni R, Piscaglia F, Bolondi L. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. Hepatology. 2008;48(5):848–857. PMID: 18328590. https://doi.org/10.1016/j.jhep.2008.02.005
10. Lelyuk VG, Lelyuk SE. The state of hemodynamics in focal liver lesions (literature review and analysis of our own observations). Sono Ace Ultrasound. 2000;6:3–14. (In Russ.).
11. Bondarevsky IYa, Bordunovsky VN, Kinzersky AYu. Possibilities of ultrasound diagnostics in revealing of focal formations of liver. Meditsinskaya vizualizatsiya = Medical Visualization. 2011;5:19–24. (In Russ.).
12. Katrich AN, Porkhanov VA. Contrast-enhanced ultrasound in differential diagnosis of focal liver lesions. Hirurgiya. Zhurnal im. N.I. Pirogova = Pirogov Journal of Surgery. 2019;6:49–59. (In Russ.). PMID: 31317941. https://doi.org/10.17116/hirurgia201906149
13. Berdnikov SN, Sholokhov VN, Patyutko YuI, Makhotina MS. Comparative analysis of data on pulse-wave elastography and elastometry of liver volume lesions in vivo and on macropreparation. Sono Ace Ultrasound. 2015;27:74–83. (In Russ.).
14. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of benign liver tumours. J Hepatol. 2016;65(2):386–398. PMID: 27085809. https://doi.org/10.1016/j.jhep.2016.04.001
15. Shchupakova AN, Lagutchev VV. Workshop on Ultrasound Diagnostics. VGMU; 2016. (In Russ.).
16. Gandolfi L, Leo P, Solmi L, Vitelli E, Verros G, Colecchia A. Natural history of hepatic haemangiomas: clinical and ultrasound study. Gut. 1991;32(6):677–680. PMID: 2060877. PMCID: 1378888. https://doi.org/10.1136/gut.32.6.677
17. Dietrich C, Mertens J, Braden B, et al. Contrastenhanced ultrasound of histologically proven liver hemangiomas. Hepatology. 2007;45(5):1139–1145. PMID: 17464990. https://doi.org/10.1002/hep.21615
18. Quaia E, Bertolotto M, Dalla Palma L. Characterization of liver hemangiomas with pulse inversion harmonic imaging. Eur Radiol. 2002;12(3):537–544. PMID: 11870467. https://doi.org/10.1007/s003300101132
19. Marrero J, Ahn J, Reddy K. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol. 2014;109(9):1328–1347. PMID:25135008. https://doi.org/10.1038/ajg.2014.213
20. Buscarini E, Danesino C, Plauchu H, et al. High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med Biol. 2004;30(9):1089–1097. PMID: 15550313. https://doi.org/10.1016/j.ultrasmedbio.2004.08.004
21. Attal P, Vilgrain V, Brancatelli G, et al. Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases. Radiology. 2003;228(2):465–472. PMID: 12819340. https://doi.org/10.1148/radiol.2282020040
22. Vidili G, De Sio L, D’Onofrio M, Mirk P, Bertolotto M, Schiavone C. SIUMB guidelines and recommendations for the correct use of ultrasound in the management of patients with focal liver disease. J Ultrasound. 2019;22(1):41–51. PMID: 30580390. PMCID: PMC6430299. https://doi.org/10.1007/s40477-018-0343-0
23. Wermke W. Sonographische DifferenzialdiagnoseLeberkrankheiten: Lehrbuch und systematischer Atlas; Grauwertbild, Farb-/Power-Doppler, gepulster Doppler, Echosignalverstärker. DeutscherArzte-Verlag, 2006.
24. Kudo M, Tochio H, Zhou P. Differentiation of hepatic tumors by color Doppler imaging: role of the maximum velocity and the pulsatility index of the intratumoral blood flow signal. Intervirology. 2004;47(3–5):154–161. PMID: 15383724. https://doi.org/10.1159/000078467
25. Bleuzen A, Tranquart F. Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue. Eur J Radiol. 2004;14 Suppl 8:53–62. PMID: 15700333. https://doi.org/10.1007/s10406-004-0079-0
26. Piscaglia F, Venturi A, Mancini M, et al. Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver. Ultraschall Med. 2010;31(3):276–282. PMID: 19941252. https://doi.org/10.1055/s-0028-1109852
27. Yen Yi-H, Wang J-H, Lu Sh-N, et al. Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia. Eur J Radiol. 2006;60(3):439–444. PMID: 16916591. https://doi.org/10.1016/j.ejrad.2006.06.007
28. Bonder A, Afdhal N. Evaluation of liver lesions. Clin Liver Dis. 2012;16(2):271–283. https://doi.org/10.1016/j.cld.2012.03.001
29. Borsukov AV, Bezaltynnyh AA, Mamoshin AV. Comparative features of transabdominal and laparoscopic ultrasound study of liver, bile ducts, gallbladder, pancreas. Vestnik novykh meditsinskikh tekhnology = Journal of New Medical Technologies. 2013;20(1):85–89. (In Russ.).
30. Bioulac-Sage P, Sempoux C, Possenti L, et al. Pathological diagnosis of hepatocellular cellular adenoma according to the clinical context. Int J Hepatol. 2013;2013:253–261. PMID: 23691330. PMCID: PMC3652210. https://doi.org/10.1155/2013/253261
31. Weskott HP. Contrast Enhanced Ultrasound. UNI-MED; 2014. (In Russ.).
32. Dietrich C, Schuessler G, Trojan J, Fellbaum C, Ignee A. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol. 2005;78(932):704–707. PMID: 16046421. https://doi.org/10.1259/bjr/88181612
33. Booth C, Nanji S, Wei X, Mackillop W. Management and outcome of colorectal cancer liver metastases in elderly patients: a population-based study. JAMA Oncol. 2015;1(8):1111–1119. PMID: 26355283. https://doi.org/10.1001/jamaoncol.2015.2943
34. Bernatik T, Schuler A, Kunze G, et al. Benefit of contrast-enhanced ultrasound (CEUS) in the follow-up care of patients with colon cancer: a prospective multicenter study. Ultraschall Med. 2015;36(6):590–593. PMID: 26544634. https://doi.org/10.1055/s-0041-107833
35. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. PMID: 29628281. https://doi.org/10.1016/j.jhep.2018.03.019
36. Siegel R, Ma J, Zou Zh, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. PMID:24399786. https://doi.org/10.3322/caac.21208 [Erratum in CA Cancer J Clin. 2014;64:364]
37. Kaprin AD, Starinsky VV, Petrova GV (eds). The State of Cancer Care for the Population of Russia in 2018. P.A. Gertsen Moscow Scientific and Research Oncology Institute, Branch of National Medical Research Center of Radiology; 2019. (In Russ.).
38. 2014 Korean Liver Cancer Study Group – National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma. Korean J Radiol. 2015;16(3):465–522. PMID: 25995680. PMCID: PMC4435981. https://doi.org/10.3348/kjr.2015.16.3.465
39. Breder VV, Balakhnin PV, Virshke ER, Kosyrev VYu, Ledin YeS, Petkau VV. Practical recommendations for drug treatment of hepatocellular cancer. Malignant Lesions: Practical Recommendations by RUSSCO. 2019;9(3-Sa):420–438. (In Russ.). https://doi.org/10.18027 / 2224-5057-2019-9-3s2-420-438
40. Parfenova AA. Differential Diagnosis of Focal Hepatic Lesions in Determining the Indications for Their Minimally Invasive Surgery. Dissertation. Volgograd State Medical University; 2007. (In Russ.).
41. Colli A, Fraquelli M, Casazza G, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance and alphafetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol. 2006;101(3):513–523. PMID: 16542288. https://doi.org/10.1111/j.1572-0241.2006.00467.x
42. Friedman S, Rockey D, Montgomery D. Hepatic fibrosis 2006: report of the third AASLD Single Topic Conference. Hepatology. 2007;45(1):242–249. PMID: 17187439. https://doi.org/10.1002/hep.21459
43. Katrich AN, Okhotina AV, Shamakhyan KA, Ryabin NS. Ultrasound shear wave elastography in the diagnosis of liver fibrosis stage. Ultrazvukovaya i funktsionalnaya diagnostika = Ultrasound and Functional Diagnostics. 2017;3:10–21.(In Russ.).
44. Park M, Han K, Kim S. Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease. Expert Rev Gastroenterol Hepatol. 2014;8(5):501–511. PMID: 24939348. https://doi.org/10.1586/17474124.2014.898563
45. Wang W, Liu J, Yang Zh, et al. Hepatocellular adenoma: comparison between real-time contrast-enhanced ultrasound and dynamic computed tomography. Springerplus. 2016;5:951. PMID: 27386395. PMCID: PMC4929102. https://doi.org/10.1186/s40064-016-2406-z
46. Dietrich C, Tana C, Caraiani C, Dong Yi. Contrast enhanced ultrasound (CEUS) imaging of solid benign focal liver lesions. Expert Rev Gastroenterol Hepatol. 2018;12(5):479–489. PMID: 29658347. https://doi.org/10.1080/17474124.2018.1464389
47. CEUS LI-RADS® v2017. American College of Radiology. Accessed February 2, 2021. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS/CEUS-LI-RADS-v2017
Review
For citations:
Katrich A.N., Polshikov S.V. MULTIPARAMETRIC ULTRASOUND IN THE DIAGNOSIS OF LIVER TUMORS. Innovative Medicine of Kuban. 2021;(1):72-78. (In Russ.) https://doi.org/10.35401/2500-0268-2021-21-1-72-78
Views:
610
Email this article 
